MRPL20 divergent transcript (MRPL20-DT)

The MRPL20 divergent transcript (MRPL20-DT) is a human long non-coding RNA (lncRNA) gene, not a protein-coding gene, and not a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel. It is transcribed but does not encode a protein, and is part of the lncRNA class of transcripts. Although “MRPL20” refers to a mitochondrial ribosomal protein, the divergent transcript (MRPL20-DT) is distinct and does not code for the MRPL20 protein. There is limited published information on its specific biological role, molecular mechanism, or involvement in disease, and there are no known drugs or direct disease associations currently described. The variant names “MRPL20-DT” and “MRPL20 divergent transcript” reflect its non-coding nature and its location adjacent or divergent to the MRPL20 gene. Its functional characterization remains incomplete; current databases categorize it only as an lncRNA with presumed roles in gene regulation or chromatin structure, but no direct biological or therapeutic role has been established[1][5]. Key points: - **This gene is not a classical drug target.** - **There is no evidence it functions as a receptor, enzyme, transporter, transcription factor, or other standard molecular target class.** - **Function is likely regulatory, as for other lncRNAs, but is uncharacterized in major databases[1][5].** - **No evidence of involvement in disease, no known interacting drugs, and no biomarker or safety data available.**

Other names

MRPL20-DTMRPL20 divergent transcript